Inventor
WU HAN-CHUNG
TW36 patents
⚠️ This page may combine multiple inventors who share the name “WU HAN-CHUNG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACADEMIA SINICA
15 patentsUS10118969B2Nov 6, 2018
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
ACADEMIA SINICA13 citations84
US10150818B2Dec 11, 2018
Compositions and methods for treatment and detection of cancers
ACADEMIA SINICA10 citations82
US9982041B2May 29, 2018
Compositions and methods for treatment and detection of cancers
ACADEMIA SINICA11 citations82
US9975965B2May 22, 2018
Compositions and methods for treatment and detection of cancers
ACADEMIA SINICA11 citations82
US9387257B2Jul 12, 2016
Lung cancer specific peptides for targeted drug delivery and molecular imaging
ACADEMIA SINICA4 citations65
US11674958B2Jun 13, 2023
Capture, purification, and release of biological substances using a surface coating
ACADEMIA SINICA0 citations60
US9187558B2Nov 17, 2015
Anti-epithelial cell adhesion molecule (EpCAM) antibodies and methods of use thereof
ACADEMIA SINICA2 citations60
US12516107B2Jan 6, 2026
Potent neutralizing antibodies for prevention and treatment of COVID-19
ACADEMIA SINICA0 citations56
US11111276B2Sep 7, 2021
Epitope-substituted vaccine for use in improving safety and immunogenicity against dengue viruses
ACADEMIA SINICA1 citations56
US10487120B2Nov 26, 2019
Epitope-substituted vaccine for use in improving safety and immunogenicity against dengue viruses
ACADEMIA SINICA1 citations56
US11524978B2Dec 13, 2022
Synthetic peptides, pharmaceutical compositions comprising the same, and uses thereof in treating thromboembolism-related diseases
ACADEMIA SINICA0 citations53
US11357862B2Jun 14, 2022
Peptide-conjugated nanoparticles for targeting, imaging, and treatment of prostate cancer
ACADEMIA SINICA0 citations53
US12527879B2Jan 20, 2026
Ligands targeted to epidermal growth factor receptors and compositions for use in treating tumors
ACADEMIA SINICA0 citations52
US10196447B2Feb 5, 2019
Anti-vascular endothelial growth factor receptor 2 (VEGFR2) antibody and methods of use thereof for detecting VEGFR2 and for inhibiting tumor growth, tumor angiogenesis and/or inducing cancer cell cytotoxicity
ACADEMIA SINICA0 citations43
US8969530B2Mar 3, 2015
Anti-clathrin heavy chain monoclonal antibody for inhibition of tumor angiogenesis and growth and application thereof
ACADEMIA SINICA0 citations42
WU HAN-CHUNG
9 patentsUS8637035B2Jan 28, 2014
Anti-dengue virus antibodies
WU HAN-CHUNG22 citations86
US8394758B2Mar 12, 2013
Tumor-targeting peptides and uses thereof
WU HAN-CHUNG10 citations81
US9150655B2Oct 6, 2015
Anti-C-met antibody and methods of use thereof
WU HAN-CHUNG4 citations68
US8088887B2Jan 3, 2012
Peptide-conjugates that bind to VEGF-stimulated or tumor vasculature and methods of treatment
WU HAN-CHUNG2 citations55
US8835605B2Sep 16, 2014
Uses of cancer-targeting peptides in cancer diagnosis
WU HAN-CHUNG0 citations49
US8674070B2Mar 18, 2014
Cancer-targeting peptides and uses thereof in cancer therapy
WU HAN-CHUNG0 citations49
US8415453B2Apr 9, 2013
Lung cancer-targeted peptides and applications thereof
WU HAN-CHUNG1 citations49
US8541543B2Sep 24, 2013
Peptides specific for hepatocellular carcinoma cells and applications thereof
WU HAN-CHUNG0 citations47
US8709806B2Apr 29, 2014
EpCAM as a reprogramming factor for non-pluripotent cells
WU HAN-CHUNG0 citations43
UNIV NAT TAIWAN
4 patentsUS7238665B2Jul 3, 2007
Peptide marker targeting to nasopharyngeal carcinoma cell and application thereof
UNIV NAT TAIWAN9 citations71
US10487119B2Nov 26, 2019
Peptides for diagnosis and treatment of cancer
UNIV NAT TAIWAN0 citations49
US7740858B2Jun 22, 2010
SARS-CoV-specific B-cell epitope and applications thereof
UNIV NAT TAIWAN0 citations46
US7901877B2Mar 8, 2011
Genetic markers and methods for detecting and treating cancers
UNIV NAT TAIWAN0 citations44
FOUNTAIN BIOPHARMA INC
3 patentsUS9758580B2Sep 12, 2017
Uses of antibodies to interleukin-6 in cancer treatment
FOUNTAIN BIOPHARMA INC1 citations56
US9234035B2Jan 12, 2016
Antibodies to interleukin-6
FOUNTAIN BIOPHARMA INC1 citations56
US10370443B2Aug 6, 2019
Method of treating autoimmune disease by administering antibodies to interleukin-6
FOUNTAIN BIOPHARMA INC0 citations45